These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16690735)

  • 1. Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology.
    Kofoed K; Schneider UV; Scheel T; Andersen O; Eugen-Olsen J
    Clin Chem; 2006 Jul; 52(7):1284-93. PubMed ID: 16690735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
    Kofoed K; Andersen O; Kronborg G; Tvede M; Petersen J; Eugen-Olsen J; Larsen K
    Crit Care; 2007; 11(2):R38. PubMed ID: 17362525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
    Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
    J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
    Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
    Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock.
    Ríos-Toro JJ; Márquez-Coello M; García-Álvarez JM; Martín-Aspas A; Rivera-Fernández R; Sáez de Benito A; Girón-González JA
    PLoS One; 2017; 12(4):e0175254. PubMed ID: 28380034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a bead-based multiplex assay for the simultaneous detection of porcine inflammation markers using xMAP technology.
    Bongoni AK; Lanz J; Rieben R; Banz Y
    Cytometry A; 2013 Jul; 83(7):636-47. PubMed ID: 23576245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum soluble triggering receptor expressed on myeloid cells-1 in acute respiratory distress syndrome: a prospective observational cohort study.
    Lin MT; Wei YF; Ku SC; Lin CA; Ho CC; Yu CJ
    J Formos Med Assoc; 2010 Nov; 109(11):800-9. PubMed ID: 21126652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis.
    Zhao JJ; Lou XL; Chen HW; Zhu FT; Hou YQ
    Cell Mol Biol Lett; 2018; 23():22. PubMed ID: 29760745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology.
    Skogstrand K; Thorsen P; Nørgaard-Pedersen B; Schendel DE; Sørensen LC; Hougaard DM
    Clin Chem; 2005 Oct; 51(10):1854-66. PubMed ID: 16081507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates.
    Sarafidis K; Soubasi-Griva V; Piretzi K; Thomaidou A; Agakidou E; Taparkou A; Diamanti E; Drossou-Agakidou V
    Intensive Care Med; 2010 May; 36(5):864-8. PubMed ID: 20232048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis.
    Saldir M; Tunc T; Cekmez F; Cetinkaya M; Kalayci T; Fidanci K; Babacan O; Erdem G; Kocak N; Sari E; Akgul EO; Kul M
    Pediatr Neonatol; 2015 Dec; 56(6):415-21. PubMed ID: 26341458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma.
    Giamarellos-Bourboulis EJ; Mouktaroudi M; Tsaganos T; Koutoukas P; Spyridaki E; Pelekanou A; Kotzampassi K
    J Trauma; 2008 Dec; 65(6):1385-90. PubMed ID: 19077631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease.
    Lasseter HC; Provost AC; Chaby LE; Daskalakis NP; Haas M; Jeromin A
    Cytokine X; 2020 Jun; 2(2):100027. PubMed ID: 33604555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor.
    Kofoed K; Eugen-Olsen J; Petersen J; Larsen K; Andersen O
    Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):375-83. PubMed ID: 18197443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapy-associated febrile neutropenia: a pilot study.
    Kwofie L; Rapoport BL; Fickl H; Meyer PW; Rheeder P; Hlope H; Anderson R; Tintinger GR
    Ann Hematol; 2012 Apr; 91(4):605-11. PubMed ID: 21976106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid diagnosis of sepsis.
    Bloos F; Reinhart K
    Virulence; 2014 Jan; 5(1):154-60. PubMed ID: 24335467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early serum levels of soluble triggering receptor expressed on myeloid cells-1 in septic patients: correlation with monocyte gene expression.
    Dimopoulou I; Pelekanou A; Mavrou I; Savva A; Tzanela M; Kotsaki A; Kardara M; Orfanos SE; Kotanidou A; Giamarellos-Bourboulis EJ
    J Crit Care; 2012 Jun; 27(3):294-300. PubMed ID: 21855288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis biomarkers reprofiling to predict stroke-associated infections.
    Bustamante A; García-Berrocoso T; Penalba A; Giralt D; Simats A; Muchada M; Zapata E; Rubiera M; Montaner J
    J Neuroimmunol; 2017 Nov; 312():19-23. PubMed ID: 28886956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of XMAP and ELISA cytokine profiles; development and validation for immunotoxicological studies in vitro.
    Codorean E; Nichita C; Albulescu L; Răducan E; Popescu ID; Lonită AC; Albulescu R
    Roum Arch Microbiol Immunol; 2010; 69(1):13-9. PubMed ID: 21053779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Triggering Receptor Expressed on Myeloid Cells-1 as a Novel Marker for Abdominal Sepsis.
    Song X; Song Y; Zhang X; Xue H
    Surg Infect (Larchmt); 2017 Jul; 18(5):577-581. PubMed ID: 28266902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.